According to The Insight Partners new research study of “Medical Second Opinion Market to 2027 – COVID-19 Impact & Global Analysis and Forecasts by Disorders (Cancer, Orthopedic Disorders, Cardiac Disorders, Neurological Disorders, Nephrological Disorders, Hematologic Blood Disorders, COPD, Organ transplant, Others); Service Providers (Hospitals, Health Insurance Companies, Online Services), and Geography,” the market is expected to reach US$ 10,739.48 Mn by 2027 from US$ 3,204.57 Mn in 2019; it is estimated to grow at a CAGR of 16.8% from 2020 to 2027.
Extensively increasing integration of medical services and digital platforms is leading to increasing popularity and acceptance of digital consultation. The digital consultation ensures patient convenience, improved patient experience, and effective cost management. Further, the deployment of digital platform enables patient to be consulted from remote locations with superior accessibility to medical expertise. Rising number of partnerships and collaborations among software developing companies and healthcare institutions is accelerating the digitalization of medical consulting services. For instance, in July 2019, University of Chicago Medicine launched remote second opinion services in collaboration with PinnacleCare, one of the key healthcare advisory companies. The system offers remote health consultation beyond geographic boundaries. Thus, the growing digitalization of medical second opinion services is estimated to offer lucrative opportunities to the market players.
Sample PDF showcases the content structure and the nature of the information included in the report which presents a qualitative and quantitative analysis – https://www.theinsightpartners.com/sample/TIPRE00011728/
Market leaders operating in the market have undertaken various organic growth strategies in the medical second opinion market. The medical second opinion market majorly consists of the players such as Medisense Healthcare Solutions Pvt. Ltd., Second Opinion International, Elite Medical Services, Cigna, Helsana, WorldCare, Vidal Health Insurance TPA Pvt Ltd, Medix, 2nd.MD, and AXA among others. Several organic approaches, such as product launches, and expansion in the medical second opinion market, have resulted in the positive growth of the market. Product launches help the company to strengthen its product offering and the customer base, which allows the company to hold a strong position in the market. Similarly, utilizing expansion activities, it is easy to venture into untapped economies and use the opportunities being offered.
The global medical second opinion market is segmented on the basis of region into North America, Europe, Asia Pacific, the Middle East and Africa, and South and Central America. North America held the largest market share in 2019. The factors fueling the market in this region include increasing prevalence of chronic disorders and growing adoption of medical second opinion to increase treatment accuracy.
Have a 15-minute-long discussion with the lead analyst and author of the report in a time slot decided by you. You will be briefed about the contents of the report and queries regarding the scope of the document will be addressed as well – https://www.theinsightpartners.com/speak-to-analyst/TIPRE00011728
Increasing number of errors in medical billing is also one of the prominent factors responsible for the growth of the market. For instance, according to a study published by the Medical Billing Advocates of America in 2019, an estimated 80.0% of medical bills contain at least one error. Further, problems in medical billing errors cost a total of ~US$ 210 billion each year in the US. These possibilities and occurrences of financial errors are projected to accelerate the growth of the medical second opinion market by 2027.
Below is the list of the growth strategies done by the players operating in the medical second opinion market:
In Jan-2021 – Teladoc Health, Inc. has announced partnership with DexCom, Inc. to empower innovative advanced technology and human expertise. Both companies have partnered to offer CGM-powered insights patient living with Type 2 Diabetes at free of cost. The CGM-powered insights will assist patients with complete health profile and will recommend tips to support their ongoing diabetes management.
In Sept-2018 – AXA Global Healthcare has announced that from 1st November, all new and existing Individual and SME customers with outpatient cover will have access to its innovative new virtual doctor service, Global Care on Demand.
In Jan-2018 – AXA the world’s 42nd largest health care brand, announced the acquisition of Maestro Health. The deal is seen as a gateway for AXA’s entry into the United States market.
Jan-2020 – USARAD Holdings Inc. has collaborated with Siemens Healthineers to develop AI-Rad Companion Chest CT software for lung nodule detection. The software will assist radiologists to detect pulmonary nodules. The software is CE marked and has received FDA’s approval for its commercialization.
Immediate delivery of our off-the-shelf reports and prebooking of upcoming studies, through flexible and convenient payment methods – https://www.theinsightpartners.com/buy/TIPRE00011728/
About Us:
The Insight Partners is a one stop industry research provider of actionable intelligence. We help our clients in getting solutions to their research requirements through our syndicated and consulting research services. We are a specialist in Technology, Healthcare, Manufacturing, Automotive and Defense, Food & beverage, Chemical and Materials, Semiconductors etc.
Contact Us:
Call: +1-646-491-9876
Email: [email protected]